J&J Topamax “Dear Doctor” Letter Advises Metabolic Acidosis Monitoring
Executive Summary
Physicians should periodically examine Topamax (topiramate) patients for metabolic acidosis, a Johnson & Johnson "Dear Health Care Professional" letter recommends
You may also be interested in...
Topamax Draws FDA Warning Letter For Promoting Unsafe Use In Children
FDA is citing Johnson & Johnson's Topamax for a website and sales aid that lack sufficient safety information
Topamax Draws FDA Warning Letter For Promoting Unsafe Use In Children
FDA is citing Johnson & Johnson's Topamax for a website and sales aid that lack sufficient safety information
J&J Focusing On “Product Solutions”; Diabetes Care May Be Early Model
Johnson & Johnson is moving towards a business model focused on offering "product solutions" for the health care system, Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia